Ergoteles’s Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant ROSS.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,900
Closed -$108K 2018
2022
Q3
$108K Hold
10,900
﹤0.01% 1352
2022
Q2
$107K Hold
10,900
﹤0.01% 1485
2022
Q1
$108K Hold
10,900
﹤0.01% 1103
2021
Q4
$109K Hold
10,900
﹤0.01% 1133
2021
Q3
$109K Hold
10,900
﹤0.01% 1086
2021
Q2
$109K Hold
10,900
﹤0.01% 1387
2021
Q1
$109K Buy
+10,900
New +$109K ﹤0.01% 729

Other funds holding ROSS.U

Ergoteles's ROSS.U Position: Q4 2022 in Review

Ergoteles sold out of Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant (ROSS.U) in Q4 2022, closing a stake of 10,900 shares — an estimated $108K sold.

Ergoteles first reported a position in ROSS.U in Q1 2021 and held it in 7 quarters. The position peaked at $109K in Q4 2021. 17 funds tracked by Wall St. Rank hold ROSS.U as of Q4 2022.

  • Ergoteles reported no remaining Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 10,900 Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant shares in Q4 2022, an estimated $108K.
  • Ergoteles first reported a position in Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • Ergoteles's Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant position peaked at $109K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.